LATS1 and breast cancer: Aberrant expression or gene mutation of LATS1 contributes to malignant transformation and histological progression in cervical squamous cell carcinoma (CSCC) [10], breast cancer [11], hepatocellular carcinoma (HCC) [12] and astrocytoma [13].